Molecular pathology evaluation is becoming increasingly integrated into the practice of anatomic pathology and laboratory medicine. The integration of molecular and genomic pathology into pathology practice is conspicuous in oncology, where definition of molecular pathways important for specific tumors has enabled development of drugs to target these pathways, and companion tests to predict which tumors are likely to respond to these targeted agents, as well as in inherited and infectious diseases and disorders. The mission of the Molecular Diagnostic Pathology SIG is to synergize the efforts of basic, translational, and clinical science researchers to increase our understanding of molecular pathways and develop diagnostic, prognostic, and therapeutic applications.
The objectives of the Molecular Diagnostic Pathology SIG are to:
ASIP Members are invited to participate in the Molecular Diagnostic Pathology SIG Listserv. Please email firstname.lastname@example.org to have your name and email address added to the listserv.
To send a message to the Molecular Diagnostic Pathology SIG Listserv, send your email to email@example.com. Please note that you must be a member of this listserv in order to send and receive messages.
Please direct all questions to: Lisa McFadden (240) 283-9712.